Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Short-term Investments (2019 - 2025)

Pulmonx (LUNG) has disclosed Short-term Investments for 6 consecutive years, with $8.8 million as the latest value for Q2 2025.

  • Quarterly Short-term Investments fell 82.85% to $8.8 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Jun 2025, down 82.85% year-over-year, with the annual reading at $30.6 million for FY2024, 8.87% down from the prior year.
  • Short-term Investments for Q2 2025 was $8.8 million at Pulmonx, down from $14.1 million in the prior quarter.
  • The five-year high for Short-term Investments was $51.1 million in Q2 2024, with the low at $8.8 million in Q2 2025.
  • Average Short-term Investments over 5 years is $30.8 million, with a median of $33.6 million recorded in 2023.
  • The sharpest move saw Short-term Investments soared 318.17% in 2022, then plummeted 82.85% in 2025.
  • Over 5 years, Short-term Investments stood at $31.6 million in 2021, then grew by 24.84% to $39.4 million in 2022, then dropped by 14.84% to $33.6 million in 2023, then decreased by 8.87% to $30.6 million in 2024, then plummeted by 71.35% to $8.8 million in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $8.8 million, $14.1 million, and $30.6 million for Q2 2025, Q1 2025, and Q4 2024 respectively.